UNSPSC 51161709: Poractant alfa

This classification denotes a respiratory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KE3U2023NP. Amiphenazole most often comes in base and hydrochloride forms. European Medicines Agency schedules Poractant Alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22150. As of Q4 2014, PORACTANT ALFA remains the US FDA Preferred Term for this commodity.

UNSPSC 51161709 Poractant alfa is a Commodity code for a surfactant medication used in neonatal respiratory distress treatment. State and local procurement activity under this code shows a fundamental mismatch: the three recent opportunities posted under this UNSPSC describe athletic training services (Tucson), general medical aid supplies including first-aid items and over-the-counter medications (Tampa Fire Rescue), and a pharmacy benefit program direct-to-manufacturer initiative (Texas HHS). None of these solicitations involve poractant alfa procurement or neonatal critical-care pharmaceuticals. The code sees no recent activity aligned with its intended scope—state and local health departments, hospital systems, neonatal intensive care units, and emergency medical services that would be the natural buyers of surfactant medications do not appear in the recent-opportunities record under this code.

The geographic spread captured in the recent-opportunities block spans Texas, Arizona, and Florida, but the activities (athletic trainer staffing, bandages and pain relievers, and pharmacy benefit program design) represent a tagging misalignment rather than genuine demand for poractant alfa. Without recent state and local solicitations specifically targeting surfactant acquisition or neonatal respiratory pharmaceuticals, this code presents no actionable procurement signal for vendors in the pharmaceutical manufacturing or distribution space focused on critical-care respiratory products.